The influence of folate pathway polymorphisms on high-dose methotrexaterelated toxicity and survival in children with non-Hodgkin malignant lymphoma

Data publikacji: 10 lip 2014

Zakres stron: 289 - 292

Otrzymano: 01 wrz 2013

Przyjęty: 16 wrz 2013

DOI: https://doi.org/10.2478/raon-2013-0076

Słowa kluczowe

childhood, non-Hodgkin lymphoma, folate pathway, polymorphism, high-dose methotrexate, toxicity

© by Vita Dolzan

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.